Here is an honest look at how it works, who it suits, and where its limits are
Check the duration
- May 28, 2026 - CVS Health (NYSE: CVS) today announced updates to its most common commercial formularies, expanding GLP-1 options for members including the reintroduction of Zepbound (tirzepatide) as a covered medication
And it turns out much of this is not strictly weight loss dependent. In the SELECT cardiovascular outcomes trial published in November 2023, semaglutide was associated with a 20% risk reduction in major adverse cardiovascular events in patients 45 years of age or older compared with placebo
In this way, it serves as a proofofconcept that even a peptide or protein drug known to have poor bioavailability can still be delivered orally, and without any modification, if we compensate by delivering a sufficiently high dose
It holds LegitScript certification, is HIPAA compliant, has a verifiable US address in Irvine, California, and uses licensed prescribers through OpenLoop Healthcare Partners